kidney disease glp 1 Glucagon-like Peptide Receptor Agonists and Outcomes in the Era of Personalized Medicine: Focus on Albuminuria Real-World Evidence for GLP-1 Receptor

They can evaluate whether your dosage of semaglutide needs to be adjusted or if another treatment option may be more suitable for you

and non-alcoholic fatty liver disease [13,14,15]

Glucagon-like peptide 1 receptor agonists, often referred to GLP-1 receptor agonists, are medications that help lower blood sugar levels by mimicking the GLP-1 hormone in the body

Shortcomings associated with DPP-IV inhibitors The previous studies revealed the most common adverse effects in patients, including infections in the respiratory passage, nasopharyngitis, headache, and bladder infections associated with sitagliptin and saxagliptin, respectively (61, 62)